Johnson & Johnson are a global pharmaceutical company with a strong track record of successful academic collaborations. They are interested in identifying research focused on novel treatments for retinal and ocular conditions.
Johnson & Johnson are looking for any novel compounds or targets which could be used for retinal neuroprotection. This includes prevention of photoreceptor/retinal ganglion cell (RGC) apoptosis or degeneration.
The photoreceptor/RGC degeneration can be linked to any condition, but Johnson & Johnson are particularly...
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.